Articles
Media
All VideosCase Based Roundtable SeriesEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsViewpoints
Publications
Digital EditionSupplements And Featured Publications
Conferences
Conference Listing
More
CME/CE
Resources
SponsoredZEISS Clinical CasesZeiss Cataract InsightsZeiss Cataract DigitalizationEnhancing the Patient JourneyEYLEA 8mg for nAMD and DME TreatmentBetween the Lines

Subscribe

  • Articles
  • Media
  • Publications
  • Conferences
  • CME/CE
  • Resources
  • Subscribe
  • AMD
  • Cataract & Refractive
  • Cornea
  • Gene Therapy
  • Glaucoma
  • Inflammation & Infection
  • Paediatrics
  • Retina
Spotlight -
ZEISS Clinical Cases|
Heidelberg Engineering: Enhancing the Patient Journey
Advertisement

Huma Qamar, MD, MPH

Advertisement

Articles by Huma Qamar, MD, MPH

The endgame of inherited retinal disease trials

ByDaniel C. Chung, DO, MA,Huma Qamar, MD, MPH,Murthy Chavali, PhD,David J. Tanzer, MD
December 26th 2025

Navigating the labyrinth of IRD research to identify objective, clinically meaningful outcomes.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Ophthalmology Times Europe

    1

    IGS 2026: Clinical pearls for detecting pre-perimetric glaucoma

    2

    IGS 2026: The expanding role of artificial intelligence in ophthalmology

    3

    Broadening horizons: Expanding your surgical portfolio with SMILE pro for Hyperopia

    4

    IGS 2026: Population-based normative data could transform AI in glaucoma

    5

    IGS 2026: Considering OCT in neuro-ophthalmology and neurological diseases

    • Advertise
    • About Us
    • Editorial Info
    • Editorial Board
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us